Newsroom – Insights, 
Announcements & Recognition

Stay up to date with Cyntegrity’s latest company news, industry and product updates, 
speaking engagements, and media appearances.

Newsroom – Insights,
Events & Recognition

Stay up to date with Cyntegrity’s latest company news, industry and product updates, 
speaking engagements, and media appearances.

Cyntegrity logo – Risk-Based Quality Management Solutions

Upcoming Events

Stay up to date with upcoming events, including new training sessions, webinars and workshops.

20 May 2026

mindsON RBQM webinar | “Managing risks across multiple trials” with Cyntegrity’s Chief Scientific OfficerDr. Johann Proeve, and  RBQM SME Keith Dorricott, MBB.
Register for free here…

21 May 2026

actON QbD webinar | “Are we moving to a new era for detecting protocol deviations?” with RBQM SME Keith Dorricott, MBB, and Cyntegrity’s Head of Growth, Julien Goncalves.
Register for free here…

21 May 2026

RQA 2026 International QA Virtual Conference | “ICH E6(R3) Compliance Using Data-Enabled Risk Intelligence: The Future Of GCP Auditing” with Cyntegrity’s CEO & Founder, Artem Andrianov, and Shenaz Vakharia, VP, APAC at ADAMAS Consulting.
Register here…

Tamara Beck, Marketing Operations Manager at Cyntegrity

Tamara Beck

Operations Manager, MyRBQM® Academy & Event Coordinator

Get in touch with Tamara for event details, co-speaking opportunities, or to connect with our alumni community.

Email

academy@cyntegrity.com

Phone Number

+49 (0) 6192 470 113 50

Website

academy.cyntegrity.com

Stay Informed with Us

AI Literacy in Clinical Trials Under ICH E6(R3)

AI-supported workflows in clinical trials increasingly fall within GCP, computerized system, data integrity, and AI governance expectations. Sponsors and CROs need teams that understand oversight, validation, accountability, and responsible AI use....

FDA Warning Letter Highlights AI Oversight Risks in Clinical Trials

FDA’s warning letter signals a shift: AI use without oversight is a compliance risk. What clinical trial teams must understand to stay inspection-ready....
It seems we can’t find what you’re looking for.

Article Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip …

The Real Cost of Trial Delays & How RBQM Reduces Risk

Clinical trial delays are costly. Learn updated cost estimates and how RBQM + QbD make studies more predictable, efficient, and patient-focused.

Media Inquiries

Need a quote, speaker, or more info about Cyntegrity? Reach out directly to our media contact for timely assistance.

AI Use in Clinical Trials Is Increasing.
So Are Regulatory Expectations.

Regulators expect controlled, documented, and reviewable AI use. Prepare your teams to apply AI within GCP and computerized system requirements.